Marc E. Lippman, M.D.

Professor and Chairman

tel: 305-243-4909
fax: 305-243-9124

Marc E. Lippman, M.D. was named the Kathleen and Stanley Glaser Professor of Medicine at the University of Miami Leonard M. Miller School of Medicine, and was named Chairman of the Department of Medicine in May 2007.  Previously Dr. Lippman was the John G. Searle Professor and Chair of Internal Medicine at the University of Michigan , Ann Arbor, Michigan .  From 1988 through 1999 Dr. Lippman was Professor of Medicine and Pharmacology, and Chair, Department of Oncology at Georgetown University in Washington, D.C., and served as Director of the Lombardi Cancer Center at Georgetown University Medical Center .  From 1978 through 1990 he was Clinical Professor of Medicine and Pharmacology, Uniformed Services, University of the Health Sciences.  Dr. Lippman served as Head of the Medical Breast Cancer Section, Medicine Branch, at the National Institute of Health.  He was a Senior Investigator at the National Cancer Institute of the National Institute of Health.  Dr. Lippman completed a Fellowship in Endocrinology at Yale Medical School in New Haven, CT from 1973-1974.  In addition, he was Clinical Associate at the National Cancer Institute from 1970-1971 and Clinical Associate at the Laboratory of Biochemistry of the National Cancer Institute of the National Institute of Health.  From 1970 to 1988 he served as an Officer and Medical Director of the United States Public Health Service.  Dr. Lippman completed his residency on the Osler Medical Service, John Hopkins Hospital , in Baltimore, Maryland from 1968-1970.

A native of New York, Dr. Lippman received his Bachelor's Degree from Cornell University , Magna Cum Laude, and medical school degree at Yale Medical School in New Haven, CT where he was elected to AOA. 

Dr. Lippman is widely known for his research in breast cancer.  Throughout his illustrious career he has received numerous awards including Mallinckrodt Award of the Clinical Radioassay Society in 1978; the Commendation Medal USPHS in 1982; Meritorius Service Medal, USPHS in 1987; Clinical Investigator Award, American Federation for Clinical Research in 1985; D.R. Edwards Lecture and Medal, Tenovus Institute, Wales 1985; Plenary Lecturer, British Association of Cancer Research in 1987;  Gosse Lecture, Dalhuosie University, Halifax Nova Scotia in 1987; the American Cancer Society Dean's Cancer Lecture, Georgetown University, 1988; Transatlantic Medal and Lecture, British Endocrine Societies, 1989; the Tiffany Award of Distinction, Komen Foundation in 1989; the Astwood Award, Endocrine Society, 1991; the Bernard Fisher Award and Lectureship, University of Pittsburgh in 1991.  He also has been the recipient of the First William P. McGuire Memorial Lecture, San Antonio, TX in 1992, and the Howard University Outstanding Achievement Award in 1993.  He also received the First American Cancer Society Lectureship and Prize at the ASCO Meeting in Orland, FL in May 1993, the AACR Rosenthal Award of the AARC in April 1994, and the Brinker Award for Basic Science of the Komen Foundation in 1994.  

Dr. Lippman owns several patents including Ligand Growth Factors that bind to the ERBB-2 Receptor protein and induce cellular responses, U.S. Patent No. 5,578,482, issued in Novermber 1996; Antibodies to Ligand Growth Factdor. U.S. Patent No. 5,869,618, issued in February 1999; Binding Peptides which Interact with Ligand Growth Factors of the Epidermal Growth Factor Receptor and erbB2 Receptor, U.S. Patent No. 5,874,528, issued in February 1999; Ligand Growth Factor GP30 that Binds t the ERBB-2 Receptor Prtein and Induces Cellular Responses, U.S. Patent No. 6,040,290, issued in 2000; and ErBB-4 Targeted Ribozymes, U.S. Patent No. 6,566,105, issued in May 2003.  

Dr. Lippman is a member of the Association of American Physicians, the American Society for Clinical Investigation, the American Society of Biological Chemists, the American Association for Cancer Research, and the American Society of Clinical Oncology.  As a researcher, Dr. Lippman has published over 400 peer reviewed articles.  In addition, he has authored many books and contributed many chapters based on his breast cancer research including a textbook on breast disease.  

Dr. Lippman has served on the Editorial Board of numerous publications including Breast Cancer Research and Treatment, for which he serves as Editor-in-Chief,  the Journal of Steroid Biochemistry, The Cancer Journal, Cancer Research, Breast Disease, Cancer Therapeutics, the LOWAD Journal Women and Cancer, Signal, and the American Journal of Oncology Review.  In addition, he has been Editor-in-Chief of Endocrine-Related Cancer.  

Dr. Lippman is a member of the Board of Directors of Ascenta Therapeutics Inc., and Seattle Genetics.

Dr. Lippman will continue his research in breast oncology at the University of Miami of Leonard M. Miller School of Medicine, in addition to his duties as Chair of the Department of Medicine.

Awards & Recognition